Pulmonary complications of solid organ and hematopoietic stem cell transplantation (Q35740698)

10 August 2017

1 reference

title

Pulmonary complications of solid organ and hematopoietic stem cell transplantation (English)

1 reference

10 August 2017

Robert M Kotloff

1

1 reference

10 August 2017

Vivek N Ahya

series ordinal

2

1 reference

10 August 2017

Stephen W Crawford

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

7 April 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

10 August 2017

1 reference

10 August 2017

170

1 reference

10 August 2017

1

1 reference

10 August 2017

22-48

1 reference

Pulmonary considerations of organ transplantation. Part I.

10 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary considerations of organ transplantation. Part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Infectious complications following isolated lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary complications in cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A positive donor gram stain does not predict outcome following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary nodules in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Lung nodular lesions in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Tuberculosis in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Risk factors for post-transplant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Mycobacterial infection in a series of 1261 renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Mycobacterial infection after renal transplantation in a Western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Disseminated Mycobacterium avium infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Diagnostic yield of bronchoscopies after isolated lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Thin-Section CT Findings in 32 Immunocompromised Patients with Cytomegalovirus Pneumonia Who Do Not Have AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Prevention and treatment of cytomegalovirus disease in heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The 2001 Garrod lecture. The treatment of cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Community respiratory viruses: organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Respiratory viruses and chronic rejection in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Community respiratory viral infection in adult lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Influenza virus infection in adult solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

CT manifestations of respiratory syncytial virus infection in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Respiratory Syncytial Virus Infections in Pediatric Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Prophylaxis and treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Influenza vaccination in heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The immunogenicity of influenza virus vaccine in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Transmission of vaccinia virus and rationale for measures for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Approaches to fungal diagnosis in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary resection for invasive Aspergillus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Cryptococcosis in organ transplant recipients: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Fungal infections in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Coccidioidomycosis in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Incidence and indications for reintubation during postoperative care following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary complications of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The pleural space and organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Right phrenic nerve injury in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Clinical risk factors for primary graft failure following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Primary graft failure following lung transplantation: predictive factors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Primary graft failure following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report--2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Interventional bronchoscopy for the management of airway complications following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A modified bronchial anastomosis technique for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

High dose rate brachytherapy in the management of lung transplant airway stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Diaphragmatic paralysis: a complication of lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Anaesthesiological complications in renal transplantation: a retrospective study of 500 transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Calcium deposition with or without bone formation in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Metastatic pulmonary calcification after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary metastatic calcification with respiratory insufficiency in patients on maintenance haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Sirolimus-induced pneumonitis: three cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Portopulmonary hypertension and the liver transplant candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The role of innate immunity in acute allograft rejection after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Statin Use Is Associated with Improved Function and Survival of Lung Allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Nonmyeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

History of haematopoietic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Outcome of recipients of bone marrow transplants who require intensive-care unit support

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Hemopoietic growth and inhibitory factors in treatment of malignancies. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Engraftment syndrome following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Predictive value of pulmonary function tests before marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Risk factors for pulmonary tuberculosis in bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

An outbreak of respiratory syncytial virus in a bone marrow transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Adenovirus infections in patients undergoing bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Caspofungin acetate for treatment of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Idiopathic pneumonia syndrome after syngeneic bone marrow transplant in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

TUMOR NECROSIS FACTOR-?? NEUTRALIZATION REDUCES LUNG INJURY AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary veno-occlusive disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pulmonary Veno-occlusive Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Treatment of Epstein-Barr virus-associated malignancies with specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Outcome of bone marrow transplantation patients requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

The role of T-cell costimulatory activation pathways in transplant rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Pneumonia After Heart Transplantation: A Multiinstitutional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1322SO

10.1164/RCCM.200309-1322SO

21 January 2018

Identifiers

DOI

1 reference

release_vgniswogejdexclw5at2mpnwnu

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vgniswogejdexclw5at2mpnwnu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference